Motion Sickness Treatment Market

Motion Sickness Treatment Market (Treatment Type - Anticholinergic, Antihistamines; Route of Administration - Oral, Transdermal; Distribution Channel - Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

  • Rep Id : TMRGL39320
  • Published On : May 2018
  • No. of Pages : 166
  • Category : Pharmaceutical

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Motion Sickness Treatment Market

4. Market Overview
     4.1. Overview
     4.2. Market Dynamics
            4.2.1. Drivers
            4.2.1. Restraints
     4.3. Global Motion Sickness Treatment Market Analysis and Forecast, 2016–2026
            4.3.1. Market Revenue Projections (US$ Mn)
     4.4. Porter’s Five Force Analysis

5. Market Outlook
     5.1.Pipeline Analysis
     5.2.Key Mergers & Acquisitions
     5.3.OTC & Prescription Market Analysis

6. Global Motion Sickness Treatment Market Analysis and Forecasts, by Treatment Type
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Market Value Forecast, by Treatment Type, 2016–2026
            6.3.1. Anticholinergic
            6.3.2. Antihistamines
            6.3.3. Others
     6.4. Market Attractiveness, by Treatment Type

7. Global Motion Sickness Treatment Market Analysis and Forecasts, by Route of Administration
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Market Value Forecast, by Route of Administration, 2016–2026
            7.3.1. Oral
            7.3.2. Transdermal
            7.3.3. Others
     7.4. Market Attractiveness, by Route of Administration

8. Global Motion Sickness Treatment Market Analysis and Forecasts, by Distribution Channel
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Market Value Forecast, by Distribution Channel, 2016–2026
            8.3.1. Retail Pharmacies
            8.3.2. Online Pharmacies
            8.3.3. Others
     8.4. Market Attractiveness, by Distribution Channel

9. Global Motion Sickness Treatment Market Analysis and Forecasts, by Region
     9.1. Key Findings
     9.2. Market Value Forecast, by Region
            9.2.1. North America
            9.2.2. Europe
            9.2.3. Asia Pacific
            9.2.4. Latin America
            9.2.5. Middle East & Africa
     9.3. Market Attractiveness, by Region

10. North America Motion Sickness Treatment Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
     10.2. Market Value Forecast, by Treatment Type, 2016–2026
            10.2.1. Anticholinergic
            10.2.2. Antihistamines
            10.2.3. Others
     10.3. Market Value Forecast, by Route of Administration, 2016–2026
            10.3.1. Oral
            10.3.2. Transdermal
            10.3.3. Others
     10.4. Market Value Forecast, by Distribution Channel, 2016–2026
            10.4.1. Retail Pharmacies
            10.4.2. Online Pharmacies
            10.4.3. Others
     10.5. Market Value Forecast, by Country, 2016–2026
            10.5.1. U.S.
            10.5.2. Canada
     10.6. Market Attractiveness Analysis
            10.6.1. By Treatment Type
            10.6.2. By Route of Administration
            10.6.3. By Distribution Channel
            10.6.4. By Country

11. Europe Motion Sickness Treatment Market Analysis and Forecast
     11.1.Introduction
            11.1.1. Key Findings
     11.2.Market Value Forecast, by Treatment Type, 2016–2026
            11.2.1. Anticholinergic
            11.2.2. Antihistamines
            11.2.3. Others
     11.3.Market Value Forecast, by Route of Administration, 2016–2026
            11.3.1. Oral
            11.3.2. Transdermal
            11.3.3. Others
     11.4.Market Value Forecast, by Distribution Channel, 2016–2026
            11.4.1. Retail Pharmacies
            11.4.2. Online Pharmacies
            11.4.3. Others
     11.5.Market Value Forecast, by Country / Sub-region, 2016–2026
            11.5.1. Germany
            11.5.2. France
            11.5.3. U.K.
            11.5.4. Italy
            11.5.5. Spain
            11.5.6. Rest of Europe
     11.6.Market Attractiveness Analysis
            11.6.1. By Treatment Type
            11.6.2. By Route of Administration
            11.6.3. By Distribution Channel
            11.6.4. By Country / Sub-region

12. Asia Pacific Motion Sickness Treatment Market Analysis and Forecast
     12.1.Introduction
            12.1.1. Key Findings
     12.2.Market Value Forecast, by Treatment Type, 2016–2026
            12.2.1. Anticholinergic
            12.2.2. Antihistamines
            12.2.3. Others
     12.3.Market Value Forecast, by Route of Administration, 2016–2026
            12.3.1. Oral
            12.3.2. Transdermal
            12.3.3. Others
     12.4.Market Value Forecast, by Distribution Channel, 2016–2026
            12.4.1. Retail Pharmacies
            12.4.2. Online Pharmacies
            12.4.3. Others
     12.5.Market Value Forecast, by Country / Sub-region, 2016–2026
            12.5.1. China
            12.5.2. Japan
            12.5.3. India
            12.5.4. Australia & New Zealand
            12.5.5. Rest of Asia Pacific
     12.6.Market Attractiveness Analysis
            12.6.1. By Treatment Type
            12.6.2. By Route of Administration
            12.6.3. By Distribution Channel
            12.6.4. By Country / Sub-region

13. Latin America Motion Sickness Treatment Market Analysis and Forecast
     13.1.Introduction
            13.1.1. Key Findings
     13.2.Market Value Forecast, by Treatment Type, 2016–2026
            13.2.1. Anticholinergic
            13.2.2. Antihistamines
            13.2.3. Others
     13.3.Market Value Forecast, by Route of Administration, 2016–2026
            13.3.1. Oral
            13.3.2. Transdermal
            13.3.3. Others
     13.4.Market Value Forecast, by Distribution Channel, 2016–2026
            13.4.1. Retail Pharmacies
            13.4.2. Online Pharmacies
            13.4.3. Others
     13.5.Market Value Forecast, by Country, 2016–2026
            13.5.1. Brazil
            13.5.2. Mexico
            13.5.3. Rest of Latin America
     13.6.Market Attractiveness Analysis
            13.6.1. By Treatment Type
            13.6.2. By Route of Administration
            13.6.3. By Distribution Channel
            13.6.4. By Country / Sub-region

14. Middle East & Africa Motion Sickness Treatment Market Analysis and Forecast
     14.1.Introduction
            14.1.1. Key Findings
     14.2.Market Value Forecast, by Treatment Type, 2016–2026
            14.2.1. Anticholinergic
            14.2.2. Antihistamines
            14.2.3. Others
     14.3.Market Value Forecast, by Route of Administration, 2016–2026
            14.3.1. Oral
            14.3.2. Transdermal
            14.3.3. Others
     14.4.Market Value Forecast, by Distribution Channel, 2016–2026
            14.4.1. Retail Pharmacies
            14.4.2. Online Pharmacies
            14.4.3. Others
     14.5.Market Value Forecast, by Country / Sub-region, 2016–2026
            14.5.1. GCC Countries
            14.5.2. South Africa
            14.5.3. Rest of Middle East & Africa
     14.6.Market Attractiveness Analysis
            14.6.1. By Treatment Type
            14.6.2. By Route of Administration
            14.6.3. By Distribution Channel
            14.6.4. By Country / Sub-region

15. Competition Landscape
     15.1.Market Player – Competition Matrix (By Tier and Size of companies)
     15.2.Market Footprint Analysis
            15.2.1. By Region
            15.2.2. By Treatment Type
     15.3. Competitive Business Strategies
     15.4. Company Profiles
            15.4.1. GlaxoSmithKline plc
                     15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.4.1.2.Product Portfolio
                     15.4.1.3.Financial Overview
                     15.4.1.4.SWOT Analysis
                     15.4.1.5.Strategic Overview
            15.4.2. Perrigo Company plc
                     15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.4.2.2.Product Portfolio
                     15.4.2.3.Financial Overview
                     15.4.2.4.SWOT Analysis
                     15.4.2.5.Strategic Overview
            15.4.3. Prestige Brands, Inc.
                     15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.4.3.2.Product Portfolio
                     15.4.3.3.Financial Overview
                     15.4.3.4.SWOT Analysis
                     15.4.3.5.Strategic Overview
            15.4.4. Wellspring Pharmaceutical Corporation
                     15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.4.4.2.Product Portfolio
                     15.4.4.3.SWOT Analysis
                     15.4.4.4.Strategic Overview
            15.4.5. Caleb Pharmaceuticals, Inc.
                     15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.4.5.2.Product Portfolio
                     15.4.5.3.SWOT Analysis
                     15.4.5.4.Strategic Overview
            15.4.6. Myungmoon Pharm CO., LTD.
                     15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.4.6.2.Product Portfolio
                     15.4.6.3.Financial Overview
                     15.4.6.4.SWOT Analysis
                     15.4.6.5.Strategic Overview
            15.4.7. Baxter International Inc.
                     15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.4.7.2.Product Portfolio
                     15.4.7.3.Financial Overview
                     15.4.7.4.SWOT Analysis
                     15.4.7.5.Strategic Overview
            15.4.8. Reliefband Technologies LLC
                     15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.4.8.2.Product Portfolio
                     15.4.8.3.Financial Overview
                     15.4.8.4.SWOT Analysis
                     15.4.8.5.Strategic Overview

List of Tables 

Table 01: Pipeline Analysis (1/2)
Table 02: Pipeline Analysis (2/2)
Table 03: Key Mergers and Acquisitions Snapshot (1/2)
Table 04: Key Mergers and Acquisitions Snapshot (2/2)
Table 05: Global Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 06: Global Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 07: Global Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 08: Global Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 09: North America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 10: North America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 11: North America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 12: North America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 13: Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 14: Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 15: Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 16: Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 17: Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 18: Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 19: Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 20: Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 21: Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 22: Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 23: Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 24: Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country / Sub-region, 2016–2026
Table 25: Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 26: Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 27: Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 28: Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 29: Key Players Market Footprint Analysis, by Treatment Type
Table 30: Key Players Market Footprint Analysis, by Region

List of Figures

Figure 01: Global Motion Sickness Treatment Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
Figure 02: Global Motion Sickness Treatment
Figure 03: Top 3 Trends
Figure 04: Global Motion Sickness Treatment Market Value Share, by Region (2017)
Figure 05: Global Motion Sickness Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 06: Global Market Value Share, by Treatment Type (2017)
Figure 07: Global Market Value Share, by Route of Administration (2017)
Figure 08: Global Market Value Share, by Distribution Channel (2017)
Figure 09: Global Market Value Share, by Region (2017)
Figure 10: OTC and Prescription Drugs Comparison Snapshot (2017)
Figure 11: Global Motion Sickness Treatment Market Value Share, by Treatment Type, 2017 and 2026
Figure 12: Global Motion Sickness Treatment Market Attractiveness Analysis, by Treatment Type, 2018–2026
Figure 13: Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anticholinergic, 2016–2026
Figure 14: Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Antihistamines, 2016–2026
Figure 15: Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 16: Global Motion Sickness Treatment Market Value Share, by Route of Administration, 2017 and 2026
Figure 17: Global Motion Sickness Treatment Market Attractiveness Analysis, by Route of Administration, 2018-2026
Figure 18: Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral Drugs, 2016–2026
Figure 19: Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Transdermal Drugs, 2016–2026
Figure 20: Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 21: Global Motion Sickness Treatment Market Value Share, by Distribution Channel, 2017 and 2026
Figure 22: Global Motion Sickness Treatment Market Attractiveness, by Distribution Channel, 2018–2026
Figure 23: Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2016–2026
Figure 24: Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2016–2026
Figure 25: Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 26: Global Motion Sickness Treatment Market Value Share, by Region, 2017 and 2026
Figure 27: Global Motion Sickness Treatment Market Attractiveness Analysis, by Region, 2018–2026
Figure 28: Market Snapshot, by Country
Figure 29: North America Motion Sickness Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 30: North America Motion Sickness Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2026
Figure 31: North America Motion Sickness Treatment Market Attractiveness Analysis, by Treatment Type, 2018– 2026
Figure 32: North America Motion Sickness Treatment Market Value Share Analysis, by Route of Administration, 2017 and 2026
Figure 33: North America Motion Sickness Treatment Market Attractiveness Analysis, by Route of Administration, 2018–2026
Figure 34: North America Motion Sickness Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 35: North America Motion Sickness Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 36: North America Motion Sickness Treatment Market Value Share Analysis, by Country, 2017 and 2026
Figure 37: North America Motion Sickness Treatment Market Attractiveness Analysis, by Country, 2018–2026
Figure 38: Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 39: Europe Motion Sickness Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2026
Figure 40: Europe Motion Sickness Treatment Market Attractiveness Analysis, by Treatment Type, 2018–2026
Figure 41: Europe Motion Sickness Treatment Market Value Share Analysis, by Route of Administration, 2017 and 2026
Figure 42: Europe Motion Sickness Treatment Market Attractiveness Analysis, by Route of Administration, 2018–2026
Figure 43: Europe Motion Sickness Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 44: Europe Motion Sickness Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 45: Europe Motion Sickness Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 46: Europe Motion Sickness Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 47: Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 48: Asia Pacific Motion Sickness Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2026
Figure 49: Asia Pacific Motion Sickness Treatment Market Attractiveness Analysis, by Treatment Type, 2018–2026
Figure 50: Asia Pacific Motion Sickness Treatment Market Value Share Analysis, by Route of Administration, 2017 and 2026
Figure 51: Asia Pacific Motion Sickness Treatment Market Attractiveness Analysis, by Route of Administration, 2018–2026
Figure 52: Asia Pacific Motion Sickness Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 53: Asia Pacific Motion Sickness Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 54: Asia Pacific Motion Sickness Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 55: Asia Pacific Motion Sickness Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 56: Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 57: Latin America Motion Sickness Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2026
Figure 58: Latin America Motion Sickness Treatment Market Attractiveness Analysis, by Treatment Type, 2018–2026
Figure 59: Latin America Motion Sickness Treatment Market Value Share Analysis, by Route of Administration, 2017 and 2026
Figure 60: Latin America Motion Sickness Treatment Market Attractiveness Analysis, by Route of Administration, 2018–2026
Figure 61: Latin America Motion Sickness Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 62: Latin America Motion Sickness Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 63: Latin America Motion Sickness Treatment Market Value Share Analysis, by Country / Sub-region, 2017 and 2026
Figure 64: Latin America Motion Sickness Treatment Market Attractiveness Analysis, by Country / Sub-region, 2018–2026
Figure 65: Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 66: Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2026
Figure 67: Middle East & Africa Motion Sickness Treatment Market Attractiveness Analysis, by Treatment Type, 2018–2026
Figure 68: Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, by Route of Administration, 2017 and 2026
Figure 69: Middle East & Africa Motion Sickness Treatment Market Attractiveness Analysis, by Route of Administration, 2018–2026
Figure 70: Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 71: Middle East & Africa Motion Sickness Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 72: Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 73: Middle East & Africa Motion Sickness Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 74: Key Competitive Strategies Snapshot

.